Introduction {#S1}
============

Insomnia is one of the most common health risk factors in the population as well as in clinical practice, which is associated with genes, neurons, environment, behavior, physiology, etc. ([@B4]; [@B11]). Insomnia is defined as the subjective perception of difficulty with sleep initiation (over 30 min of sleep latency), duration, and consolidation, resulting in dissatisfied sleep quality despite adequate opportunity for sleep ([@B29]). The understanding of the whole dynamics of the sleep--wake cycle could lead us to a better solution on insomnia, which is controlled by interactive neurochemical processes among multiple neural structures ([@B8]; [@B3]).

Insomnia has gradually become a prevalent phenomenon in fast-paced urban life. Insomnia occurs among individuals of different ages ([@B16]; [@B20]), and symptoms occur in approximately 33--50% of the adult population ([@B1]). Insomnia is the most prevalent and accounts for almost half of all sleep disorders (15% of the whole population) ([@B6]). Due to the complexity of the neural system that controls sleep, it is a great challenge to accurately diagnose and treat insomnia.

During the past few years, a wide range of hardware including wearable devices has enabled us to access more personal health performance via mobile applications and help improved our health. However, the reliability and validation vary among different applications ([@B28]). For insomnia management and improvement, it is critical to develop a set of comprehensive sleep valuation as well as following therapies ([@B17]).

This review summarizes the recent progress in sleep quality monitoring and non-drug sleep improvement, with a comprehensive analysis on the related advantages and limitations, trying to conclude effective suggestions for sleep problems improvement in general.

Sleep Quality Monitoring {#S2}
========================

Insomnia should be properly diagnosed before treatment. Subjective sleep quality assessment is mainly through subtly developed questionnaires. The most commonly used forms are the *Morning Evening Questionnaire (MEQ)*, *Pittsburgh Sleep Quality Index (PSQI)*, *the Hamilton scale*, etc. ([@B30]; [@B13]; [@B5]). PSQI sleep quality assessment was invented by the University of Pittsburgh and was most frequently used. It contains nine questions with each answer scoring between 0 and 3. The PSQI index is calculated as the sum of all the scores. The lower the score is, the better the sleep quality. Clinical studies have shown that the PSQI demonstrates high reliability and validity to analyze sleep problems under many circumstances, but just like other self-report inventories, its scores can be easily affected by the testee ([@B9]; [@B25]).

Sleep doctors routinely use a device called polysomnography recorder (PSG) for sleep quality monitoring ([@B14]). The PSG records electroencephalogram (EEG), electromyogram (EMG), electrocardiogram (ECG), respiration, and body movements along with other vital signs. Polysomnography is commonly used for sleep quality assessment, therapy, and sleep disorders ([@B10]). There are several limitations to obtain high quality of PSG data, including the first night effect in decreased sleep efficiency due to the unfamiliar environment and lack of comfort brought by the test, the difference in PSG variables by sex and different age groups, the control subjects, research angles and environments of different lab groups, and so on, thus making PSG hard for normalization ([@B27]; [@B2]).

Presently, new technologies and innovations on *wearables* have made sleep monitoring easy to use and enable us to access sleep data in a real-world environment, compared to PSG ([@B18]). Recent systematic reviews on the sleep monitoring methods have been introduced to value sleep quality, emphasizing the powerful innovation of wearables and the application on athletes, which allows complementary access with respect to classical sleep quality valuation and diagnose insomnia and its severity level ([@B28]; [@B7]). Comparison on the result between PSG and wearables has shown consistency but needs further refinement for reliability ([@B21]).

The new Apple watch not only has a sleep monitoring function but also achieved CFDA approval for early warning of atrial fibrillation. A small electrocardiographic device developed by Harvard University infers sleep quality by cardiopulmonary coupling (CPC) monitoring ([@B31]). These products are relatively simple in structure when compared to the PSG and are much more comfortable to wear. Most sleep monitoring devices in the consumer market refer to actigraph (body movement), heart rate, and heart rate variability (HRV) to predict sleep structure, to evaluate the quality of sleep ([@B19]). Other products with comparable functions include wrist bands, sleep monitoring belts, and radar beam trackers. One of such examples is the sleep monitoring belt based on piezoelectric sensing technology developed by an Israeli company named EarlySense and a Finlandizei company called Beddit recently acquired by Apple.

The accuracy of these consumable products, however, has been challenged by medical doctors, and whether they could replace the PSG device for clinical use is yet to be determined. However, a recent trend on the cooperation between the pharmaceutical and wearable companies has been shaping. For instance, Eli Lily and Apple have started large-scale clinical trials on Alzheimer's disease, with the help of iPhones, watches, and sleep monitor belt.

Non-Drug Therapy and Sleep Improvement Techniques for Insomnia {#S3}
==============================================================

Currently, most insomnia patients take hypnotic drugs for treatment. However, a large percentage of the population feel reluctant to take sleeping pills, and this led to the development of non-drug insomnia therapeutics. Non-drug treatment of insomnia is divided into two major categories: cognitive behavioral therapy for insomnia (CBT-I), which is performed in the absence of auxiliary devices ([@B26]), and physiotherapy through repetitive transcranial magnetic resonance (rTMS), white noise and music, aromatherapy, and light therapy devices.

*Cognitive behavioral therapy (CBT)* is a fairly simple and easy way to treat insomnia. It can relieve insomnia through such behavioral interventions as sleep restriction, stimulus control, and paradoxical intervention. For example, sleep restriction allows a subject to stay in bed only when he or she feels sleepy and this gradually improves sleep quality by increasing sleep efficiency ([@B24]). Stimulus control improves sleep quality by limiting non-sleep behaviors in the bed and establishing good bed-sleep conditioned reflexes ([@B12]). No auxiliary devices are needed for CBT-I, but the drawback of this tool is its low compliance rate.

*Repetitive transcranial magnetic stimulation (rTMS)* relieves insomnia by lowering the level of arousal for the targeted cerebral cortex ([@B15]). Low-frequency (\<1 Hz) repetitive transcranial stimulation inhibits the excitement of the cerebral cortex and can induce slow waves, a brain wave that mostly appears as a subject enters deep sleep. Although this method is effective, the equipment is too large for consumable commercialization.

*White noise* refers to the combination of sound of multiple frequencies. White noise diminishes the excessive concentration of attention to relax the mood and alleviate insomnia ([@B23]). Most natural sounds such as wind, rain, water flow, and other natural sounds all belong to the white noise family. White noise is often used in conjunction with soothing music to regulate mood and help with sleep.

*Aromatherapy* and *meditation* are commonly used together. Both methods are considered to be effective in reducing psychological stress. The fragrance of natural flowers and plants has been accompanying human beings into dreams throughout the 2 million years of evolution. We used to live in the jungle, mountains, or grasslands. It is thought that the awakened memories in ancient times help us fall into sleep faster. Meditation helps people relax and rapidly fall asleep by distracting attention and reducing anxiety ([@B22]).

*Light therapy* is gaining increasing attention from doctors and hospitals. The principle of light therapy is to adjust the phase and amplitude of biological clock oscillation through specific light stimulation, so as to establish and consolidate a regular sleep--wake cycle and improve the quality of sleep ([@B32]). Light therapy products have been developed in the form of large light boards and small desktop lightboxes. Recently, head-mounted light therapy glasses have been invented to improve portability and ease of use. The innovation has dramatically increased the patients' compliance with light therapy.

Discussion and Conclusion {#S4}
=========================

Having a better knowledge on sleep physiology and insomnia is important for both health and medical reasons. Although we lack further understanding of the nerve system controlling the sleep--wake cycle, it doesn't stop us from seeking better monitoring and treatment on insomnia.

The pre-programmed passive wearables provide us a new angle to understand sleep, together with the classical evaluation form and PSG, shaping a comprehensive monitoring ecosphere and potential synergistic effect for clinical, post-hospital, and daily needs.

On the other hand, we need a better solution to improve sleep disorder, and there has been progress showing that, besides sleep medications, we do have more effective choices owing to the development of non-drug insomnia therapeutic.

The availability of digitized data in clinical and daily scenarios, combined with the arrival of powerful artificial intelligence (AI) algorithms, could bring deeper implications for health and medicine industry. New medicine or non-drug equipment like light therapy will speed up the upgrade.

The health innovation system should promote such progress by working closely with hospitals, pharmaceutical companies, and academic institutes. Proper guidance should be given to educate the public on the limitations along with the promotion of health technologies.
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